Skip to main content
SpringerLink
Log in

Cholecalciferol (Vitamin D3) Inhibits Growth and Invasion by Up-regulating Nuclear Receptors and 25-Hydroxylase (CYP27A1) in Human Prostate Cancer Cells

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Epidemiological evidence suggests an inverse relationship between prostate cancer and serum vitamin D levels. We examined the ability of cholecalciferol (vitamin D3), a calcitriol precursor, to inhibit or reverse cellular changes associated with malignant transformation and invasion and explored its mechanisms of action. The RWPE2-W99 human prostate epithelial cell line, which forms slow-growing tumors in nude mice, was used because it mimics the behavior of the majority of primary human prostate cancers. Cholecalciferol, at physiological levels: (i) inhibited anchorage-dependent and -independent growth; (ii) induced differentiation by decreasing vimentin expression with a concomitant decrease in motility/chemotaxis; (iii) decreased MMP-9 and MMP-2 activity with concomitant decrease in invasion; and (iv) exerted its effects by up-regulating vitamin D receptor (VDR), retinoid-X receptor-α (RXR-α), and androgen receptor (AR) in a dose-dependent manner. Furthermore, we found that RWPE2-W99 prostate cancer cells, similar to RWPE-1 cells (Tokar and Webber. Clin Exp Metast 2005; 22: 265–73), constitutively express the enzyme 25-hydroxylase CYP27A1 which is markedly up-regulated by cholecalciferol. Cholecalciferol has effects similar to those of calcitriol on growth, MMP activity, and VDR. The ability of CYP27A1 to catalyze the conversion of cholecalciferol to 25(OH)D3 and of 25(OH)D3 to calcitriol has been reported. RWPE2-W99 cells, similar to RWPE-1 cells, appear to have the rare ability to locally convert cholecalciferol to the active hormone calcitriol. Because it can inhibit cellular changes associated with malignant transformation and invasion, we propose that cholecalciferol may be an effective agent for the treatment of prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

25(OH)D3:

25-hydroxyvitamin D3

AR:

androgen receptor

CFE:

colony forming efficiency

MMP:

matrix metalloproteinase

MTT:

3-[4,5-dimethylthiazol-2-yl]-2,5-diphenly tetarzolium

PAI-1:

plasminogen activator inhibitor

PSA:

prostate specific antigen

PZ:

peripheral zone

RXR:

retinoid X receptor

UPA:

urokinase-type plasminogen activator

UVR:

ultraviolet radiation

VDR:

vitamin D receptor

References

  1. EJ Tokar MM. Webber (2005) ArticleTitleChemoprevention of human prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells Clin Exp Metastasis 22 265–73 Occurrence Handle16158254

    PubMed  Google Scholar 

  2. CL Hanchette GG Schwartz (1992) ArticleTitleGeographic patterns of prostate cancer mortality Cancer 70 2861–9 Occurrence Handle1451068 Occurrence Handle1:STN:280:ByyD1c3mt1E%3D

    PubMed  CAS  Google Scholar 

  3. GG Schwartz BS Hulka (1990) ArticleTitleIs vitamin D deficiency a risk factor for prostate cancer? (Hypothesis) Anticancer Res 10 1307–12 Occurrence Handle2241107 Occurrence Handle1:CAS:528:DyaK3MXhvVCitrk%3D

    PubMed  CAS  Google Scholar 

  4. Webber MM, Weiner SM, Rehman SMM, et al. Carcinoma of the prostate: Geographic distribution and risk factors, In Webber MM (ed) in Vitro Models for Cancer Research Boca Raton: CRC Press 1988; 5: 3–24

  5. MH Ahonen L Tenkanen L Teppo et al. (2000) ArticleTitleProstate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) Cancer Causes Control 11 847–52 Occurrence Handle10.1023/A:1008923802001 Occurrence Handle11075874 Occurrence Handle1:STN:280:DC%2BD3M3osVeqtw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  6. EH Corder HA Guess BS Hulka et al. (1993) ArticleTitleVitamin D and prostate cancer: A prediagnostic study with stored sera Cancer Epidemiol Biomarkers Prev 2 467–72 Occurrence Handle8220092 Occurrence Handle1:STN:280:ByuD3svnt10%3D

    PubMed  CAS  Google Scholar 

  7. MF Holick D Vitamin (2002) ArticleTitleThe underappreciated D-lightful hormone that is important for skeletal and cellular health Curr Opin Endocrinol Diabetes 9 87–98 Occurrence Handle10.1097/00060793-200202000-00011 Occurrence Handle1:CAS:528:DC%2BD38Xnt1alu70%3D

    Article  CAS  Google Scholar 

  8. D Feskanisch J Ma CS Fuchs et al. (2004) ArticleTitlePlasma vitamin D metabolites and risk of colorectal cancer in women Cancer Epidemiol Biomarkers Prev 13 1502–08

    Google Scholar 

  9. PR Holt N Arber B Halmos et al. (2002) ArticleTitleColonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D Cancer Epidemiol Biomarkers Prev 11 113–9 Occurrence Handle11815408 Occurrence Handle1:CAS:528:DC%2BD38XhvFGitbc%3D

    PubMed  CAS  Google Scholar 

  10. TE Robsahm S Tretli A Dahlback et al. (2004) ArticleTitleVitamin D3 from sunlight may improve the prognosis of breast-, colon-, and prostate cancer (Norway) Cancer Causes Control 15 149–58 Occurrence Handle10.1023/B:CACO.0000019494.34403.09 Occurrence Handle15017127

    Article  PubMed  Google Scholar 

  11. R Mehta M Hawthorne L Uselding et al. (2000) ArticleTitlePrevention of N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats by 1α-hydroxyvitamin D5 J Natl Cancer Inst 92 1836–40 Occurrence Handle11078761 Occurrence Handle1:CAS:528:DC%2BD3cXos1Ohsr4%3D

    PubMed  CAS  Google Scholar 

  12. X Wang NM Ponzio GP Studzinski (1997) ArticleTitleLong-term exposure of HL60 cells to 1,25-dihydroxyvitamin D3 reduces their tumorigenicity A model for cancer chemoprevention Proc Soc Exper Biol Med 215 399–404 Occurrence Handle1:CAS:528:DyaK2sXlsFWmu7o%3D

    CAS  Google Scholar 

  13. J Kovi MY Heshmat (1973) ArticleTitleIncidence of cancer in negroes in Washington, D.C. and selected African cities Am J Epidemiol 96 401–13

    Google Scholar 

  14. GJ Miller GE Stapleton JA Ferrara et al. (1992) ArticleTitleThe human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1α,25-dihydroxyvitamin D3 Cancer Res 52 515–20 Occurrence Handle1370648 Occurrence Handle1:CAS:528:DyaK38Xht1Grur4%3D

    PubMed  CAS  Google Scholar 

  15. GJ Miller GE Stapleton TE Hedlund et al. (1995) ArticleTitleVitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1α,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines Clin Cancer Res 1 997–1003 Occurrence Handle9816072 Occurrence Handle1:CAS:528:DyaK2MXoslSmt7w%3D

    PubMed  CAS  Google Scholar 

  16. X-Y Zhao DM Peehl NM Navone et al. (2000) ArticleTitle1α,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms Endocrinology 141 2548–56 Occurrence Handle10875257 Occurrence Handle1:CAS:528:DC%2BD3cXlt1Wmtbc%3D

    PubMed  CAS  Google Scholar 

  17. GG Schwartz M-H Wang M Zhang et al. (1997) ArticleTitle1α,25-dihydroxyvitamin D3 (calcitriol) inhibits the invasiveness of human prostate cancer cells Cancer Epidemiol Biomarkers Prev 6 727–32 Occurrence Handle9298581 Occurrence Handle1:CAS:528:DyaK2sXmtlSjsrw%3D

    PubMed  CAS  Google Scholar 

  18. TC Chen GG Schwartz KL Burnstein et al. (2000) ArticleTitleThe in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1α,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer Clin Cancer Res 6 901–8 Occurrence Handle10741714 Occurrence Handle1:CAS:528:DC%2BD3cXisVaqtbs%3D

    PubMed  CAS  Google Scholar 

  19. S Vos Particlede S Holden D Heber et al. (1997) ArticleTitleEffects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines Prostate 31 77–83 Occurrence Handle9140119

    PubMed  Google Scholar 

  20. GG Schwartz LW Whitlach TC Chen et al. (1998) ArticleTitleHuman prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3 Cancer Epidemiol Biomarkers Prev 7 391–95 Occurrence Handle9610788 Occurrence Handle1:CAS:528:DyaK1cXjsV2ltrc%3D

    PubMed  CAS  Google Scholar 

  21. MM Webber D Bello-DeOcampo S Quader et al. (1999) ArticleTitleModulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR) Clin Exp Metastasis 17 255–63 Occurrence Handle10.1023/A:1006665616932 Occurrence Handle10432011 Occurrence Handle1:CAS:528:DyaK1MXlsFSiu7k%3D

    Article  PubMed  CAS  Google Scholar 

  22. D Bello MM Webber HK Kleinman et al. (1997) ArticleTitleAndrogen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18 Carcinogenesis 18 1215–23 Occurrence Handle10.1093/carcin/18.6.1215 Occurrence Handle9214605 Occurrence Handle1:CAS:528:DyaK2sXktF2ltbo%3D

    Article  PubMed  CAS  Google Scholar 

  23. MM Webber D Bello HK Kleinman et al. (1997) ArticleTitleAcinar differentiation by non-malignant immortalized human prostatic epithelial cells and its loss by malignant cells Carcinogenesis 18 1225–31 Occurrence Handle10.1093/carcin/18.6.1225 Occurrence Handle9214606 Occurrence Handle1:CAS:528:DyaK2sXktF2ltbs%3D

    Article  PubMed  CAS  Google Scholar 

  24. MM Webber STA Quader HK Kleinman et al. (2001) ArticleTitleHuman cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression Prostate 47 1–13 Occurrence Handle10.1002/pros.1041 Occurrence Handle11304724 Occurrence Handle1:CAS:528:DC%2BD3MXjtVCjurg%3D

    Article  PubMed  CAS  Google Scholar 

  25. B Lehmann O Tiebel M Meurer (1999) ArticleTitleExpression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents–a preliminary study Arch Dermatol Res 291 507–10 Occurrence Handle10.1007/s004030050445 Occurrence Handle10541881 Occurrence Handle1:CAS:528:DyaK1MXnsFSksro%3D

    Article  PubMed  CAS  Google Scholar 

  26. STA Quader D Bello-DeOcampo DE Williams et al. (2001) ArticleTitleEvaluation of the chemopreventive potential of retinoids using a novel in vitro human prostate carcinogenesis model Mut Res 496 153–61 Occurrence Handle1:CAS:528:DC%2BD3MXls1ehtLs%3D

    CAS  Google Scholar 

  27. R Montironi G Lucarini C Castaldini et al. (1996) ArticleTitleImmunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia Anticancer Res 16 2057–62 Occurrence Handle8712742 Occurrence Handle1:STN:280:BymA3Mvks1A%3D

    PubMed  CAS  Google Scholar 

  28. M Stearns ME. Stearns (1996) ArticleTitleEvidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression Oncol Res 8 69–75 Occurrence Handle8859777 Occurrence Handle1:STN:280:ByiD3M3psVU%3D

    PubMed  CAS  Google Scholar 

  29. K Koli J Keski-Oja (2000) ArticleTitle1α,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells Cell Growth Different 11 221–9 Occurrence Handle1:CAS:528:DC%2BD3cXisFOmtbc%3D

    CAS  Google Scholar 

  30. A Waghray MM Webber (1995) ArticleTitleRetinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells Clin Cancer Res 1 747–53 Occurrence Handle9816041 Occurrence Handle1:CAS:528:DyaK2MXnt1Cgtb0%3D

    PubMed  CAS  Google Scholar 

  31. SH Lang C Hyde IN Reid et al. (2002) ArticleTitleEnhanced expression of vimentin in motile prostate cell lines in poorly differentiated and metastatic prostate carcinoma Prostate 52 253–63 Occurrence Handle10.1002/pros.10088 Occurrence Handle12210485 Occurrence Handle1:CAS:528:DC%2BD38XntFertb4%3D

    Article  PubMed  CAS  Google Scholar 

  32. D Krill P DeFlavia R Dhir et al. (2001) ArticleTitleExpression patterns of vitamin D receptor in human prostate J Cell Biochem 82 566–72 Occurrence Handle10.1002/jcb.1185 Occurrence Handle11500934 Occurrence Handle1:CAS:528:DC%2BD3MXlvFKrtrY%3D

    Article  PubMed  CAS  Google Scholar 

  33. K Prüfer J Barsony (2002) ArticleTitleRetinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor Mol Endocrinol 16 1738–51 Occurrence Handle12145331

    PubMed  Google Scholar 

  34. Y Lotan XC Xu M Shalev et al. (2000) ArticleTitleDifferential expression of nuclear retinoid receptors in normal and malignant prostates J Clin Oncol 18 116–21 Occurrence Handle10623701 Occurrence Handle1:CAS:528:DC%2BD3cXmtFSrug%3D%3D

    PubMed  CAS  Google Scholar 

  35. DD Kephart PG Walfish H DeLuca et al. (1996) ArticleTitleRetinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response element in yeast Mol Endocrinol 10 408–19 Occurrence Handle10.1210/me.10.4.408 Occurrence Handle8721985 Occurrence Handle1:CAS:528:DyaK28XitFSltL8%3D

    Article  PubMed  CAS  Google Scholar 

  36. LW Whitlatch MV Young GG Schwartz et al. (2002) ArticleTitle25-hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer J Steroid Biochem Mol Biol 81 135–40 Occurrence Handle10.1016/S0960-0760(02)00053-5 Occurrence Handle12137802 Occurrence Handle1:CAS:528:DC%2BD38Xls1Whsrg%3D

    Article  PubMed  CAS  Google Scholar 

  37. JA Bauer TA Thompson DR Church et al. (2003) ArticleTitleGrowth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1α,24-dihydroxyvitamin D2 Prostate 55 159–167 Occurrence Handle10.1002/pros.10219 Occurrence Handle12692781 Occurrence Handle1:CAS:528:DC%2BD3sXktF2rs78%3D

    Article  PubMed  CAS  Google Scholar 

  38. TM Beer KM Hough M Garzotto et al. (2001) ArticleTitleWeekly high-dose calcitriol and docetaxel in advanced prostate cancer Sem Oncol 28 49–55 Occurrence Handle1:CAS:528:DC%2BD3MXotVemtr8%3D

    CAS  Google Scholar 

  39. JR Muindi Y Peng DM Potter et al. (2002) ArticleTitlePharmacokinetics of high-dose oral calcitriol: results from a phase I trial of calcitriol and paclitaxel Clin Pharmacol Ther 72 648–59 Occurrence Handle10.1067/mcp.2002.129305 Occurrence Handle12496746 Occurrence Handle1:CAS:528:DC%2BD3sXltF2qtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  40. G Liu G Wilding MJ Staab et al. (2003) ArticleTitlePhase II study of 1α-Hydroxyvitamin D2 in the treatment of advanced androgen-independent prostate cancer Clin Cancer Res 9 4077–83 Occurrence Handle14519629 Occurrence Handle1:CAS:528:DC%2BD3sXns1OjtL0%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Zoology and Medicine, Michigan State University, East Lansing, Michigan, USA

    Erik J. Tokar & Mukta M. Webber

Authors
  1. Erik J. Tokar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mukta M. Webber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mukta M. Webber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tokar, E.J., Webber, M.M. Cholecalciferol (Vitamin D3) Inhibits Growth and Invasion by Up-regulating Nuclear Receptors and 25-Hydroxylase (CYP27A1) in Human Prostate Cancer Cells. Clin Exp Metastasis 22, 275–284 (2005). https://doi.org/10.1007/s10585-005-8393-z

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-005-8393-z

Keywords

Search

Navigation